MedPlus Health Services Limited share price

MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness items, such as prescription medicines, over-the-counter drugs, vitamins, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. …Read more

Website NSE हिंदी में BSE

Consumer ServicesPharmaceutical RetailersNifty Microcap 250NSE: MEDPLUSISIN INE804L01022

16 Oct 2026, 3:29 PM IST₹611.95▼ 0.85 (0.14%)

Market Cap₹ 7,349 Cr.
Current Price₹ 611.95
High / Low₹ 1,022 / 609
Stock P/E34.9
Book Value₹ 165
Dividend Yield0.00 %
ROCE12.2 %
ROE11.80 %
Face Value₹ 2.0

More figures (10)

EPS (TTM)₹ 17.52
Price / Book3.72
OPM5.0 %
Debt / Equity0.72
Sales growth (3Y)14.8 %
Profit growth (3Y)63.7 %
Promoter holding32.3 %
EV / EBITDA20.7
Beta0.46
All-time high₹ 1,343

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
MEDPLUS	-6.73%	-24.35%	-29.61%	-24.20%	-19.47%	-7.14%	—
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

MedPlus Health Services Limited is in the Pharmaceutical Retailers industry (Healthcare), with a market value of ₹7,349 crore.
It trades at 34.9 times its last 12 months' earnings and 3.7 times book value.
Revenue grew 14.8% a year over the last 3 years, profit 63.7% a year.
Return on equity was 11.8% and return on capital employed 12.2% in the latest year.
Debt was 0.72 times shareholders' equity.
The share price is 40.1% below its 52-week high and down 19.5% over one year.
Promoters and insiders hold about 32.3%; institutions about 39.2%.

Pros

Profit has grown 63.7% a year over the last 3 years.
Trades at 34.9 times earnings, below its 3-year median of 71.7.
Promoters have raised their holding by 1.19 points over 3 years, to 40.19%.
Institutional (FII + DII) holding has risen by 6.3 points over 3 years.

Cons

Return on equity has been low: 8.4% on average over the last 3 years.
Latest quarter (Jun 2026): profit fell 22% from a year ago.
The company has not paid a dividend recently.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About MedPlus Health Services Limited

Employees: 28,872
Head office: Hyderabad
NSE industry: Consumer Services

HealthcareConsumer ServicesPharmaceutical Retailers

Part ofNifty Microcap 250

S.No.	Company	CMP ₹	P/E	Mar Cap ₹ Cr	Div Yld %	NP Qtr ₹ Cr	Qtr Profit Var %	Sales Qtr ₹ Cr	Qtr Sales Var %	ROCE %	ROE %	P/B	OPM %	Debt / Eq	Prom. Hold. %	Sales ₹ Cr	Sales Var 3Yrs %
1.	MedPlus Health Services	611.95	34.9	7,349	0.00	33	-21.67	1,880	21.84	12.2	11.8	3.72	5.0	0.72	32.34	6,892	14.8
2.	Eternal	325.30	692.1	2,99,692	0.00	92	135.90	20,211	246.49	2.9	1.2	9.62	-0.1	0.15	21.78	54,364	97.7
3.	Avenue Supermarts	3,342.00	69.9	2,18,002	0.00	743	8.49	19,644	17.80	16.4	12.9	8.35	6.0	0.10	78.91	68,821	17.1
4.	Trent	2,958.70	87.2	1,57,767	0.14	519	20.79	5,755	17.84	28.2	27.6	22.59	12.0	0.37	41.86	19,850	34.8
5.	FSN E-Commerce Ventures	345.00	387.6	98,865	0.00	80	243.22	2,782	29.10	24.0	14.6	68.70	4.4	0.86	56.13	9,929	24.7
6.	ITC Hotels	162.48	39.1	33,846	0.63	180	35.42	929	14.82	9.2	7.3	2.90	25.9	0.01	46.35	4,109	16.5
7.	EIH	302.25	26.6	18,902	0.51	117	245.95	657	14.54	16.2	12.7	3.59	30.6	0.05	70.52	2,940	13.3
8.	Devyani International	121.93	—	15,033	0.00	15	—	1,581	30.34	4.3	-2.9	9.75	3.4	2.45	65.42	5,571	23.3
9.	CarTrade Tech	3,011.40	65.1	14,640	0.00	51	22.53	201	18.67	11.0	9.5	5.80	28.5	0.06	6.38	774	28.7
10.	IndiaMART InterMESH	1,627.20	19.9	9,786	1.84	172	12.18	414	11.37	20.0	20.7	4.41	32.2	0.01	58.08	1,569	16.8
	Median: 10 Co.	478.48	65.1	26,374	0.00	105	22.53	1,730	18.26	14.2	12.3	7.08	9.0	0.13	51.24	6,232	20.2

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Consolidated figures in ₹ crore /

₹ Cr	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	1,441	1,490	1,489	1,576	1,561	1,510	1,543	1,679	1,806	1,864	1,880
YOY Sales Growth %					8.32%	1.28%	3.61%	6.54%	15.67%	23.50%	21.84%
	1,350	1,385	1,395	1,452	1,429	1,373	1,412	1,530	1,648	1,695	1,746
Material Cost %	78%	77%	78%	76%	75%	73%	74%	74%	74%	74%	76%
Employee Cost %	11%	11%	11%	11%	12%	13%	13%	13%	13%	13%	13%
Other Expenses %	5%	5%	5%	4%	4%	5%	5%	5%	4%	5%	5%
Operating Profit	92	106	94	124	133	136	131	149	159	169	133
OPM %	6%	7%	6%	8%	8%	9%	8%	9%	9%	9%	7%
Other Income	10	10	9	12	13	16	15	17	18	21	20
Interest	24	25	25	25	26	27	27	29	31	33	33
Depreciation	57	59	60	63	62	64	66	69	73	76	78
Profit before tax	20	32	18	48	57	61	53	69	73	80	42
	31%	-5%	19%	19%	19%	16%	20%	19%	21%	20%	21%
Current tax	10	9	6	14	16	13	14	20	21	22	11
Deferred tax	-4	-10	-3	-5	-5	-3	-4	-7	-5	-6	-3
	14	34	14	39	46	51	42	56	58	64	33
Minority share	-0	0	-0	-0	-0	-0	0	0	-0	-0	-0
Profit to shareholders	14	33	14	39	46	51	42	56	58	64	33
YOY Profit Growth %					234.70%	52.92%	195.20%	43.42%	25.98%	24.66%	-21.67%
EPS in Rs	1.15	2.81	1.20	3.24	3.84	4.32	3.54	4.63	4.82	5.33	2.76
Raw filing

₹ Cr	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	148	148	178	156	177	202	184	206	223	248	223
YOY Sales Growth %					19.38%	35.98%	3.12%	31.63%	26.14%	22.94%	21.08%
	137	135	160	139	158	178	160	179	194	221	194
Material Cost %	78%	76%	78%	75%	77%	77%	75%	75%	76%	77%	75%
Employee Cost %	8%	8%	6%	8%	7%	6%	7%	6%	6%	6%	6%
Other Expenses %	7%	8%	5%	7%	6%	5%	6%	5%	5%	6%	5%
Operating Profit	11	13	18	17	19	24	24	27	29	27	29
OPM %	7%	9%	10%	11%	11%	12%	13%	13%	13%	11%	13%
Other Income	2	2	2	2	2	3	3	3	3	2	3
Interest	2	2	2	2	2	2	2	2	2	1	2
Depreciation	6	6	6	7	7	7	7	7	7	5	7
Profit before tax	4	6	12	10	12	18	18	21	22	23	23
	25%	-57%	20%	20%	22%	22%	23%	24%	24%	28%	24%
Current tax	1	-0	3	2	3	4	5	5	6	7	6
Deferred tax		-4	-1	0	-0	0	-1	-0	-0	-0	-1
	3	10	9	8	9	14	14	16	17	17	17
YOY Profit Growth %					193.88%	41.00%	46.21%	101.77%	76.92%	19.24%	28.95%
EPS in Rs	0.27	0.83	0.77	0.65	0.78	1.17	1.13	1.31	1.38	1.39	1.45
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Consolidated figures in ₹ crore /

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	3,779	4,558	5,625	6,136	6,892	7,229
YOY Sales Growth %		20.59%	23.42%	9.09%	12.33%
	3,507	4,292	5,271	5,649	6,285	6,620
Material Cost %	79%	78%	78%	76%	74%	74%
Employee Cost %	10%	12%	11%	12%	13%	13%
Other Expenses %	3%	4%	5%	5%	5%	5%
Operating Profit	272	266	354	487	607	610
OPM %	7%	6%	6%	8%	9%	8%
Other Income	31	46	40	49	71	76
Interest	66	83	96	103	120	126
Depreciation	119	182	224	250	283	295
Profit before tax	118	47	73	183	275	264
	20%	-6%	11%	18%	20%	20%
Current tax	30	18	27	48	78
Deferred tax	-7	-21	-19	-15	-22
	95	50	66	150	220	210
Minority share	-1	0	0	-0	-0	-0
Profit to shareholders	96	50	65	150	220	210
YOY Profit Growth %		-47.10%	30.88%	129.09%	46.18%
EPS in Rs	8.55	4.17	5.48	12.57	18.33	17.54

Compounded Sales Growth

3 Years:: 15%
TTM:: 17%

Compounded Profit Growth

3 Years:: 64%
TTM:: 18%

Stock Price CAGR

3 Years:: -7%
1 Year:: -19%

Return on Equity

4 Years:: 7%
Last Year:: 12%

₹ Cr	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	146	214	467	713	861	899
YOY Sales Growth %		46.81%	118.31%	52.69%	20.68%
	142	201	435	635	753	787
Material Cost %	81%	73%	75%	77%	76%	76%
Employee Cost %	9%	13%	9%	7%	6%	6%
Other Expenses %	7%	7%	9%	6%	5%	5%
Operating Profit	3	13	32	78	107	112
OPM %	2%	6%	7%	11%	12%	12%
Other Income	10	16	7	9	11	11
Interest	3	7	8	9	8	8
Depreciation	5	15	24	27	26	27
Profit before tax	6	8	7	51	83	89
		27%	-36%	21%	25%	25%
Current tax		2	1	11	23
Deferred tax			-4	-0	-2
	6	6	10	40	62	66
YOY Profit Growth %		-0.63%	72.82%	320.99%	54.73%
EPS in Rs	0.50	0.46	0.80	3.37	5.21	5.53

Compounded Sales Growth

3 Years:: 59%
TTM:: 25%

Compounded Profit Growth

3 Years:: 124%
TTM:: 49%

Stock Price CAGR

3 Years:: -7%
1 Year:: -19%

Return on Equity

4 Years:: 7%
Last Year:: 12%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	24	24	24	24
Reserves	1,467	1,554	1,717	1,951
Borrowings	900	1,010	1,120	1,424
	406	417	500	533
Trade payables	260	253	299	307
Minority interest	-1	-1	-1	-1
Current liabilities	477	526	577	689
Total Liabilities	2,797	3,005	3,360	3,933
	1,118	1,203	1,262	1,578
Gross block	1,589	1,815	2,005	2,528
Accumulated depreciation	471	612	743	949
Goodwill & intangibles	49	52	51	49
CWIP	27	7	14	33
	1,651	1,795	2,084	2,321
Inventories	1,144	1,340	1,345	1,382
Trade receivables	7	12	8	23
Cash & equivalents	228	91	86	198
Current assets	1,481	1,568	1,844	2,069
Total Assets	2,797	3,005	3,360	3,933

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	90	144	540	496
Profit for the year	50	65	150	220
Working capital changes	-216	-231	49	-99
Direct taxes paid	-14	-29	-45	-74
	429	-83	-318	-128
Fixed assets purchased	-169	-84	-59	-123
Fixed assets sold	0	2	1	0
Investments purchased	-115	-110	-633	-824
Investments sold	691	96	360	787
	-170	-198	-228	-256
Interest paid	-83	-96	-103	-120
Net Cash Flow	350	-137	-5	112
Free Cash Flow	-79	59	481	373

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	—	3.3%	4.3%	9.1%	11.8%
ROCE	—	5.6%	6.9%	10.3%	12.2%
Operating margin	—	1.9%	2.4%	4.2%	5.0%
Net margin	—	1.1%	1.2%	2.5%	3.2%
Debt / equity	—	0.60	0.64	0.64	0.72
Current ratio	—	3.11	2.98	3.20	3.00
Debtor days	—	1	1	0	1
Inventory days	—	117	111	106	99
Days payable	—	27	21	24	22
Cash conversion cycle	—	91	91	82	78
Working capital days	—	81	68	76	74

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 40.19%
FIIs 12.58%
DIIs 31.89%
Public 15.29%

%	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	39.00%	40.39%	40.39%	40.39%	40.39%	40.34%	40.32%	40.29%	40.29%	40.22%	40.19%	40.19%
	12.97%	14.94%	14.85%	14.72%	15.23%	15.61%	16.42%	16.54%	16.83%	15.53%	14.38%	12.58%
Foreign portfolio investors (Cat. I)	12.82%	14.79%	14.63%	14.11%	14.33%	15.04%	15.63%	15.85%	16.13%	14.94%	13.96%	12.19%
Foreign portfolio investors (Cat. II)	0.14%	0.15%	0.22%	0.61%	0.90%	0.57%	0.80%	0.68%	0.70%	0.59%	0.42%	0.39%
	25.18%	22.47%	22.17%	27.97%	25.65%	26.19%	26.04%	26.52%	26.57%	27.82%	29.95%	31.89%
Mutual funds	15.40%	12.87%	12.25%	18.08%	21.51%	21.59%	21.47%	21.48%	21.48%	22.60%	24.51%	27.39%
Insurance companies	0.89%	0.92%	1.12%	3.03%	2.47%	2.26%	2.17%	2.24%	2.29%	2.37%	2.43%	1.19%
Alternative investment funds	8.90%	8.68%	8.80%	6.87%	1.68%	2.34%	2.39%	2.79%	2.81%	2.85%	3.01%	3.31%
	22.75%	22.10%	22.52%	16.85%	18.69%	17.82%	17.18%	16.61%	16.26%	16.40%	15.44%	15.29%
Retail (up to ₹2 lakh)	3.79%	5.04%	5.27%	8.93%	9.58%	9.11%	8.69%	9.05%	9.13%	9.31%	9.02%	8.96%
HNIs (above ₹2 lakh)	2.37%	2.26%	2.29%	2.91%	3.63%	3.99%	3.90%	3.17%	2.76%	2.52%	1.88%	1.84%
NRIs	0.55%	0.59%	0.62%	0.82%	0.88%	0.90%	0.89%	0.89%	0.91%	0.91%	0.90%	0.83%
Bodies corporate	3.70%	1.89%	2.01%	3.11%	3.75%	3.11%	3.18%	3.03%	3.00%	3.22%	3.20%	3.11%
No. of Shareholders	66,049	74,976	76,934	87,328	83,912	83,439	81,742	78,337	79,157	77,278	76,005	77,714

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Mutual funds & institutions holding MedPlus Health Services

Holder (above 1%)	Stake
ICICI Prudential Healthcare FundMutual fund	7.46%
Nippon Life India Trustee Ltd-A/C Nippon India PhaMutual fund	7.32%
Franklin India Flexi Cap FundMutual fund	3.90%
SBI ELSS Tax Saver FundMutual fund	3.39%
Kotak Small Cap FundMutual fund	3.31%
Bajaj Life Insurance LimitedInsurance	1.04%

As named in the shareholding pattern for Sep 2026 filed with NSE; mutual funds together hold 27.39% of the company. Shareholders below 1% are not named in the filing.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Ex-dividend date: 1 Jan 1970
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Latest news

In the news

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about MedPlus Health Services Limited

What is the share price of MedPlus Health Services Limited today?

MedPlus Health Services Limited (MEDPLUS) last traded at ₹611.95 on NSE (16 Oct 2026, 3:29 PM IST). Prices may be delayed.

What is the market cap of MedPlus Health Services Limited?

About ₹7,349 crore at the latest price.

What is the P/E ratio of MedPlus Health Services Limited?

About 34.9 times its earnings over the last 12 months.

Is MedPlus Health Services Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy MedPlus Health Services Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.

MedPlus Health Services Limited share price

Price chart

Quick take

Pros

Cons

AI analysis

About MedPlus Health Services Limited

Peer comparison

Quarterly Results

Profit & Loss

Projection — your assumptions

Related party transactions

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Mutual funds & institutions holding MedPlus Health Services

Documents

Announcements

Annual reports

Credit ratings

Concalls & investor meets

Key dates

Trade with our broking desk

Latest news

In the news

From the company (NSE)

Questions about MedPlus Health Services Limited

Have a question about this topic?

Book your free wealth consultation

Request received!

What happens next